New pill shows promise against tough prostate cancer
Disease control
Recruiting now
This study tests a daily pill called zanzalintinib in 30 men with aggressive variant prostate cancer that has spread. The goal is to see if the drug can slow or stop cancer growth. Participants take the pill once a day and are monitored for side effects and how long the cancer st…
Phase: PHASE2 • Sponsor: Deepak Kilari • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC